Molly Divine, BS

Clinical Trials Associate II

Molly Divine began working with the ViTAL Center for Vanderbilt Tobacco, Addiction and Lifestyle as a Clinical Trials Associate II in 2021. Her work with ViTAL has primarily focused on the Metabolism Informed Smoking Treatment (MIST) and Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS) trials.

Molly earned her Bachelor of Science in Psychology from Kent State University in 2019. Prior to her employment at Vanderbilt University Medical Center, she worked as a Research Assistant in the Pediatric Health & Stress Lab at Kent State University’s Department of Psychology. Her research experience includes areas such as mindfulness, stress reduction, weight management, and smoking cessation. Molly has had the opportunity to work with a diverse range of underserved research populations, including adolescents from low-income backgrounds, pregnant women, and adults enrolled in Centers for Medicare and Medicaid (CMS).

Molly Divine completed the Certified Tobacco Treatment Training Program (CTTTP) in July 2021 through The University of Texas MD Anderson Cancer Center.